PEPTINEO - Trademark Details
Status: 710 - Cancelled - Section 8
Serial Number
85419217
Registration Number
4407576
Word Mark
PEPTINEO
Status
710 - Cancelled - Section 8
Status Date
2020-06-05
Filing Date
2011-09-09
Registration Number
4407576
Registration Date
2013-09-24
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2012-04-03
Law Office Assigned Location Code
L70
Employee Name
DUBOIS, MICHELLE E
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use
Goods and Services
Synthetic peptides for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; diagnostic preparations for medical use; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders. Biological preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological products, namely, a drug delivery system comprising peptides or proteins which extend the effect of a wide variety of therapeutic agents, for medical use and for use in medical treatment. Pharmaceutical products, namely, allergy medications, pain medication, acne medication, adrenal hormone preparations, analgesics, anaesthetics for surgical and non-surgical use, antacids, antiarrhythmics, antibacterial pharmaceuticals, antibiotics, anticoagulants, anticonvulsants, antidepressants, antidiabetic preparations, antiemetics, antihistamines, antihypertensives, antiparasitics, antiseptics, antitoxic sera, antivirals, anti-arthritic compositions and preparations, anti-cancer preparations, anti-cough preparations, anti-dermoinfectives, anti-diabetic pharmaceuticals, anti-infectives, anti-inflammatories, anti-sarcoma preparations, anti-venin, aspirin preparations, anti-bacterial and bacteriological preparations for medical purposes, beta blockers, bronchial dilators, burn relief medication, cardiovascular pharmaceuticals, central nervous system stimulants, chemotherapeutics, chloramphenicol preparations, cholesterol reducers, chondroitin preparations, cold sore treatment and/or prophylaxis preparations, contraceptive preparations, cough treatment and/or prophylaxis preparations, decongestants, dermatological pharmaceutical products, diaphoretics, dietary supplements, diuretics, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, emetics, emmenagogues, erythromycin preparations, fertility enhancement preparations, food supplements, gastro-intestinal treatment and/or prophylaxis preparations, germicides, glaucoma agents, hair growth stimulants, headache treatment and/or prophylaxis preparations, hemorrhoid treatment and/or prophylaxis preparations, hormone preparations, hydrocortisone preparations, hypnotics, pharmaceuticals for treatment and/or prophylaxis of anaphylactic reactions, insulin preparations, lactagogues, medical diagnostic reagents, medicated mouth care and treatment preparations, medicated skin care preparations, medicated hair care preparations, migraine treatment and/or prophylaxis preparations, mixed antibiotic preparations, mixed vitamin preparations, motion sickness treatment preparations, muscle relaxants, nail fungus treatment and/or prophylaxis preparations, nasal spray preparations, nausea treatment and/or prophylaxis preparations, ophthalmic preparations, ophthalmologic preparations, pain relief medication, pancreas hormone preparations, oral contraceptives, parasiticides for medical use, penicillin preparations, pharmaceutical antitussive-cold preparations, pharmaceutical anti-allergic preparations and substances, pharmaceuticals for the treatment of erectile dysfunction, appetite suppressants. anti-obesity preparations, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparations for the treatment and/or prophylaxis of gout, pharmaceutical preparations for the treatment and/or prophylaxis of heart rhythm disorders, pharmaceutical preparations for the treatment and/or prophylaxis of infectious diseases, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment and/or prophylaxis of gastro-intestinal diseases, pharmaceutical preparations for inhalation for the treatment and/or prophylaxis of pulmonary hypertension, pharmaceutical preparations for the treatment and/or prophylaxis of chronic pulmonary disease, pharmaceutical preparations for ocular or intraocular surgery, pharmaceutical preparations for the treatment and/or prophylaxis of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating and/or prophylaxis of allergic rhinitis and asthma, pharmaceutical preparations for treating and/or prophylaxis of diabetes, pharmaceutical preparations for treating and/or prophylaxis of skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for wounds, pharmaceutical preparations for use in urology, blood clotting aid and delivery systems for use in human medicine, pharmaceutical preparations for the treatment and/or prophylaxis of eye diseases and conditions, pharmaceutical products and preparations for preventing skin blemishes during pregnancy, pharmaceutical products for opthalmological use, pharmaceutical products for the treatment and/or prophylaxis of bone diseases, pharmaceutical products for the treatment and/or prophylaxis of viral and infectious diseases, for the treatment and/or prophylaxis of cancer, pharmaceutical products for treating and/or prophylaxis of respiratory diseases and asthma, lipid lowering agents, psychotropics, pituitary hormone preparations, preparations for the suppression of hormones. Preparations for treating and/or prophylaxis of colds, radiation sickness treating agents, sedatives, steroids, medications for use in weight reduction programs, streptomycin preparations, prescription synthetic narcotics, synthetic peptides for pharmaceutical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, tetracycline preparations, thiolutin preparations, threonine preparations, tranquilizers, tumor suppressing agents, vaccines, all containing antibodies or antibody fragments for medical use and for use in medical treatment; medical preparations, namely, antibodies, antibody fragments, proteins, chimeric proteins and enzymes for treatment of pain, central nervous system, inflammatory, respiratory, neoplastic, autoimmune, infection, neurological, cardiovascular, and gastrointestinal diseases and conditions, and cancer
Goods and Services
Imaging apparatus and instruments for use in the study of proteins and peptides in drug development
Goods and Services
Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of new technology for others in the field of in-vitro screening and protein engineering; biochemical research and development; biotechnological engineering and biomedical engineering; Research and development in the pharmaceutical and biotechnology fields
Goods and Services
Consulting in the field of intellectual property licensing
Translation of Words in Mark
The wording "PEPTINEO" has no meaning in a foreign language.
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2020-06-05
Primary Code
042
First Use Anywhere Date
2012-11-20
First Use In Commerce Date
2012-11-20
International Class
045 - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals. - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2020-06-05
Primary Code
045
First Use Anywhere Date
2012-11-20
First Use In Commerce Date
2012-11-20
Correspondences
Name
ZAGVISTA, LLC
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2011-09-13 | NEW APPLICATION ENTERED IN TRAM |
2011-09-15 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2011-12-27 | ASSIGNED TO EXAMINER |
2012-01-04 | NON-FINAL ACTION WRITTEN |
2012-01-04 | NON-FINAL ACTION E-MAILED |
2012-01-04 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2012-02-01 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2012-02-01 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2012-02-01 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2012-02-21 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2012-02-24 | ASSIGNED TO LIE |
2012-02-28 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2012-03-14 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2012-04-03 | PUBLISHED FOR OPPOSITION |
2012-04-03 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2012-05-29 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2012-11-29 | TEAS STATEMENT OF USE RECEIVED |
2012-12-04 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2012-11-29 | USE AMENDMENT FILED |
2012-12-04 | STATEMENT OF USE PROCESSING COMPLETE |
2013-01-08 | SU - NON-FINAL ACTION - WRITTEN |
2013-01-08 | NON-FINAL ACTION E-MAILED |
2013-01-08 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2013-08-22 | SU-EXAMINER'S AMENDMENT WRITTEN |
2013-08-22 | EXAMINERS AMENDMENT E-MAILED |
2013-08-22 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2013-08-22 | EXAMINER'S AMENDMENT ENTERED |
2013-08-22 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2013-08-22 | LAW OFFICE REGISTRATION REVIEW COMPLETED |
2013-08-23 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2013-09-24 | REGISTERED-PRINCIPAL REGISTER |
2018-09-24 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
2020-06-05 | CANCELLED SEC. 8 (6-YR) |